@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/L01AD02> a ns1:ATCConcept ;
    skos:notation "L01AD02" ;
    skos:prefLabel "Lomustin"@cs,
        "Lomustine"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0012676> a ns1:Ingredient ;
    ns1:contraindicatedWith <http://linked.opendata.cz/resource/ndfrt/disease/N0000000999>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000010195> ;
    ns1:description "An alkylating agent of value against both hematologic malignancies and solid tumors.     "@en ;
    ns1:hasMechanismOfAction <http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000236> ;
    ns1:hasMedicinalProduct <http://linked.opendata.cz/resource/sukl/medicinal-product/CEENU-LOMUSTINE--CCNU--100-MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/CEENU-LOMUSTINE--CCNU--40-MG> ;
    ns1:hasPharmacologicalAction <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028268> ;
    ns1:hasPhysiologicEffect <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008576>,
        <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008577>,
        <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009011> ;
    ns1:mayTreat <http://linked.opendata.cz/resource/ndfrt/disease/N0000000609>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000000813>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001550>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001751>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001883>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001910>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001969> ;
    ns1:title "Lomustin"@cs,
        "Lomustine"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028268> a ns1:PharmacologicalAction ;
    ns1:description "A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026)     "@en ;
    ns1:title "Antitumorózní látky alkylující"@cs,
        "Antineoplastic agents, alkylating"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000609> a ns1:DiseaseOrFinding ;
    ns1:description "Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.     "@en ;
    ns1:title "Nádory mozku"@cs,
        "Brain neoplasms"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000813> a ns1:DiseaseOrFinding ;
    ns1:description "Tumors or cancer of the COLON.     "@en ;
    ns1:title "Kolon - nádory"@cs,
        "Colonic neoplasms"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:description "Immunologically mediated adverse reactions to medicinal substances used legally or illegally.     "@en ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001550> a ns1:DiseaseOrFinding ;
    ns1:description "A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.     "@en ;
    ns1:title "Hodgkinova nemoc"@cs,
        "Hodgkin disease"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001751> a ns1:DiseaseOrFinding ;
    ns1:description "Tumors or cancers of the KIDNEY.     "@en ;
    ns1:title "Nádory ledvin"@cs,
        "Kidney neoplasms"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001883> a ns1:DiseaseOrFinding ;
    ns1:description "Tumors or cancer of the LUNG.     "@en ;
    ns1:title "Plíce - nádory"@cs,
        "Lung neoplasms"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001910> a ns1:DiseaseOrFinding ;
    ns1:description "Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.     "@en ;
    ns1:title "Lymfom non-hodgkinův"@cs,
        "Lymphoma, non-hodgkin"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001969> a ns1:DiseaseOrFinding ;
    ns1:description "A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)     "@en ;
    ns1:title "Melanom"@cs,
        "Melanoma"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000010195> a ns1:DiseaseOrFinding ;
    ns1:description "The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.     "@en ;
    ns1:title "Těhotenství"@cs,
        "Pregnancy"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000236> a ns1:MechanismOfAction ;
    ns1:title "Alkylating Activity"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008576> a ns1:PhysiologicEffect ;
    ns1:title "Decreased DNA Integrity"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008577> a ns1:PhysiologicEffect ;
    ns1:title "Decreased DNA Replication"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009011> a ns1:PhysiologicEffect ;
    ns1:title "Decreased Transcription to RNA"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product/CEENU-LOMUSTINE--CCNU--100-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/L01AD02> ;
    ns1:title "CEENU LOMUSTINE (CCNU) 100 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/CEENU-LOMUSTINE--CCNU--40-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/L01AD02> ;
    ns1:title "CEENU LOMUSTINE (CCNU) 40 MG"@cs .


